Bonum Certa Men Certa

J A Kemp Pushing the Boundaries of Patent Scope in Europe With Antibodies and SPCs

Even the USPTO isn't too clear on antibody patent policies

"...currently there is an apparent tension between the USPTO guideline with which antibody patents are granted and the case law with which the validity of existing antibody patents is determined. The antibody “exception” of the USPTO written description guideline says that a claim for an isolated antibody binding to an antigen satisfies the written description requirement even when the specification only describes the antigen and does not have working or detailed prophetic examples of antibodies that bind to the antigen. United States Patent and Trademark Office, Revised Interim Written Description Guidelines Training Materials (1999) at 59–60 [hereinafter Training Materials]; United States Patent and Trademark Office, Written Description Training Materials, Revision 1 (March 25, 2008) at 45–46 [hereinafter Revised Training Materials]. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history. The relationship between Centocor and the USPTO guideline is not clear. Although many commentators generally agree that Centocor at least restricts the scope of the antibody exception, they disagree over interpretation of the post-Centocor antibody exception." (Source: "Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott")

Summary: Patent maximalism is still a serious and an urgent issue for the EPO to tackle; the Office seems to have been dedicated to the interests of litigation firms rather than science and technology sectors

THERE are two types of patents that we oppose; one is software patents and the other is 'life' patents, or patents which pertain to what already exists in nature (or manipulated slightly from what's in nature) as those aren't actually inventions but monopolies on life itself. Ramifications include food prices, breeding, public health (e.g. cancer effects), and access to medicine. The EPC sets limits (if not outright bans) on both types of patents, but the EPO's management doesn't give a damn. Production, production, production (where "production" gets measured in terms of granted patents).

“The EPC sets limits (if not outright bans) on both types of patents, but the EPO's management doesn't give a damn.”There have been many articles lately about António Campinos; it's all about trademarks and hours ago it was reported that his agency (EU-IPO) had passed France.com to someone else, in effect taking it away from its longtime owner. Remember that Campinos is a Frenchman and recall the trademark stories about Battistelli at INPI. It does make one wonder what sorts of maximalists we deal with here.

“We've recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe.”Where does the EPO go from here as far as patent scope is concerned? Will Campinos undo the great damage caused by Battistelli on purely technical grounds (never mind the corruption and abuses)?

We've recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe. John Leeming from J A Kemp wrote about software patents earlier this year and earlier this month they spoke about antibodies, with the obligatory promotion of Supplementary Protection Certificates (SPCs)]. J A Kemp was again mentioned here very recently (it does promotion of "Patenting Antibodies at the EPO").

Well, SPCs (related to UPC) are in many headlines this month because of a decision/announcement from European authorities and yesterday we spotted Mondaq's spam/promotion, with statements like "ask your usual J A Kemp contact."

It's titled "Antibodies In The European Patent Office" (similar but not directly related to patents on life) and it speaks of patentability criteria as follows:

The European Patent Office (EPO) applies the same basic patentability criteria to antibodies as to other inventions, but it can sometimes appear that antibodies are treated as a special case. For an explanation of the basic approach adopted by the EPO, please see our related briefing Antibodies in the European Patent Office – Basic Principles or ask your usual J A Kemp contact. The present briefing is intended to develop those Basic Principles into a guide to the drafting and prosecution of patent applications for antibody inventions.

The briefing focuses on the most common type of antibody invention at the present time – namely monoclonal antibody products for which the target and any associated disease indications are already known. We also provide guidance on ensuring your antibody claims are appropriate to support future applications for Supplementary Protection Certificates (SPCs).


It's no secret that some of the biggest pushers for UPC are large pharmaceutical firms, which want to then impose SPCs and cement their monopolies. If the EPO obeys their malicious agenda, which threatens to spread software patents in the whole of Europe in one fell swoop (we know that the EPO recklessly grants these), then our challenges with the EPO as far as patent scope and litigation scope (UPC) are concerned will take priority.

"We've spoken about these issues for nearly a decade, but it's only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly."Our concern about this isn't isolated. IP2Innovate, which fronts for technology firms, has just released this press release and told us about it. Amaury Libbrecht, Policy Manager at IP2Innovate, told us about "supporting innovation in Europe through a balanced Europe patent system..."

Notice the repeated warnings about patent trolls in Europe -- a subject which patent trolls' front groups like IAM (together with Team UPC) tried hard to deny.

The latest from IP2Innovate, Libbrecht has told us, "identifies some imbalances in Europe's patent legal system (i.e. quasi automatic injunctions, bifurcation/injunction gap, ineffective fee-shifting, poor patent quality and lack of transparency) and point out solutions to address these problems..."

We've spoken about these issues for nearly a decade, but it's only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly.

Recent Techrights' Posts

EPO Staff Representatives Confront the President Who Says 'F--king' in Front of Female Workers Over Measurable Discrimination Against Female Colleagues
Central Staff Committee versus Lukashenko's sponsor
IBM Layoffs in 'RTO' Clothing Reported by Thomas Claburn
This "hey hi" (AI) nonsense is just a go-to excuse that IBM and GAFAM (and many others) use
Still Waiting for the EU to Abolish the Illegal and Unconstitutional Court Linked to EPO Corruption and Lobbyism by the Patent Litigation Industry
Sadly, all the blogs that used to talk about those issues have been infiltrated and then completely hijacked by the very perpetrators of the illegality
[Video] Richard Stallman Questions and Answers Session in Google's YouTube or Invidious
From last night
Slopwatch: Anti-Linux Articles Published by Bots, Dominating Google News
So a lot of the Web is Microsoft chatbot-generated anti-Linux FUD
 
Links 14/02/2025: Measles Outbreak in Texas, Zelensky Warns Russia Will Attack a NATO Country
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, February 13, 2025
IRC logs for Thursday, February 13, 2025
Gemini Links 13/02/2025: gwit and Restart
Links for the day
Links 13/02/2025: Algorithm Bots and 'Teleport' Breakthrough
Links for the day
Social Engineering of the Free Software Movement is a Corporate Takeover With Code of Conduct (CoC) to Drive Out or Expel Dissent
Richard Stallman (RMS) covered "cancel culture"
Links 13/02/2025: Mass Layoffs at Google (Disguised as "Buyouts"), Telecoms Price Hikes as Collusion/Price-Fixing
Links for the day
Gemini Links 13/02/2025: Broken Watches and Naming Types
Links for the day
Corrupt Bill Gates Worming His Way Into Richard Stallman Videos in Google's YouTube
Reputation laundering riding other people's names?
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, February 12, 2025
IRC logs for Wednesday, February 12, 2025
Links 12/02/2025: Crytek Layoffs, Security Holes, and Giving Ukraine to Russia
Links for the day
Relaying GAFAM Talking Points and Lies Using GAFAM LLMs, or Slop Pasted in by Brittany Day
linuxsecurity.com is relaying slop, i.e. misinformation
Photos From This Evening's Talk by Dr. Richard Stallman in Torino, Maybe a Video Soon
The talk that Dr. Richard Stallman gave today (a few hours ago) was recorded and streamed
IlSoftware.it Covers Richard Stallman's Visit to Give Talks in Italy
The publication is in Italian, the talk was in English
Macho Patent Office
At the EPO there's always room for women in top roles
Gemini Links 12/02/2025: "Bream Gives Me Hiccups", Making Chinese Tea, and More
Links for the day
This is Why Codeberg Issues an Apology Today
This response was clear and relatively swift
The Register Studies (to Affirm) Reports of IBM Layoffs "at the Finance and Operations business unit"
something about that specific unit
Links 12/02/2025: SSL FUD, DEI Phase-out, Felonies Committed by MElon (Data Breaches)
Links for the day
Italian Media Covers Richard Stallman's English Talk Ahead of Tonight's Public Appearance
article in La Stampa
Destruction and Distortion of Information, Including Facts About Linux (Bonus: This is Destroying the Planet)
All that LLMs have going for them is hype, and moreover media that intentionally misrepresents them and their supposed capabilities
Google Seems to Have Just Killed All Instances of Invidious
YouTube is rapidly becoming just "another Neflix"
Microsoft Skype in a Freefall: About 20% Decrease in Site Traffic in 3 Months (Amid Microsoft Phasing Out Credits)
Microsoft axing more services/features may mean that now they scrape the bottom of the barrel and Skype will simply die, discontinuing service (like ICQ) in a matter of years
Gemini Links 12/02/2025: Depression, Gabbro, WikiTok, and More
Links for the day
Links 12/02/2025: Health, Security, and Monopolies
Links for the day
Gemini Protocol is Increasingly Important to the Net
Gemini Protocol will turn 6 this summer
Former EPO Manager Warns That the Illegal 'Court' for "Unitary Patents" Enables “Law Shopping”
Daniel X. Thomas opposed the very existence of the UPC, which any honest person could recognise was both illegal and unconstitutional
Like GAFAM, the EPO is Passing the Financial Pains to Staff
the EPO is operating illegally at this point
Morale at Microsoft Ruined by the Company Labelling Thousands of Workers 'Low Performers', Sacking Them on the Spot and Denying Them Basic Benefits
people laid off as "low performers" go to social control media to bemoan the label
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, February 11, 2025
IRC logs for Tuesday, February 11, 2025